RAPID PRECLINICAL DEVELOPMENT OF A NOVEL ORAL MEDICINE FOR PREVENTION AND TREATMENT OF ENTEROTOXIGENIC ESCHERICHIA COLI DIARRHEAL DISEASE.
$1,539,634FY2021Defense Health AgencyDOD
University Of Massachusetts Medical School, Worcester MA
University Of Massachusetts Medical School, Worcester MA